<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04872452</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00146085</org_study_id>
    <nct_id>NCT04872452</nct_id>
  </id_info>
  <brief_title>Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders</brief_title>
  <official_title>Analysis of Cutaneous Nerve Biopsies in Gastrointestinal Motility Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to evaluate cutaneous nerve biopsies from patients with refractory&#xD;
      gastrointestinal motility disorders. The purpose of the study is to evaluate skin biopsies&#xD;
      for signs of small fiber neuropathy in GI dysmotility patients, which may provide a better&#xD;
      understanding of the underlying pathology of their condition. Specifically, identifying any&#xD;
      small fiber neuropathy that may exist in the peripheral nervous system may help us to better&#xD;
      understand the mechanism of presumed enteric neuropathy that may be involved in causing GI&#xD;
      dysmotility.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Gather basic, clinical information and perform small 3-6mm skin biopsies.&#xD;
&#xD;
        2. Identify characteristics of epidermal nerve fibers in patients with symptoms of&#xD;
           gastrointestinal dysmotility&#xD;
&#xD;
        3. To isolate skin-derived precursor cells from skin biopsies and test their ability to&#xD;
           generate neurons in vitro and in immune-deficient mouse models.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 22, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of small fiber neuropathy in skin biopsy samples</measure>
    <time_frame>Only one biopsy but analysis may take one year.</time_frame>
    <description>Presence or absence of small fiber neuropathy obtained after the skin biopsy procedure.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Small Fiber Neuropathy</condition>
  <condition>Gastrointestinal Dysmotility</condition>
  <arm_group>
    <arm_group_label>Gastrointestinal dysmotility participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy participants</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Skin biopsy</intervention_name>
    <description>Any combination of the following six 3-6mm skin biopsies may be taken: palm, dorsum of hand, calf, other non-genital and non-face (this last one includes areas for use as negative controls which are not on the distal limbs). No more than 6 biopsies will be taken at one time.The biopsy size 3-6mm and method (punch, shave or wedge) will be done depending on the biologic assay destined for the biopsy. While 3mm will be sufficient for microarray analysis, 6mm will be required for any cell sorting preceding microarray analysis.</description>
    <arm_group_label>Gastrointestinal dysmotility participants</arm_group_label>
    <arm_group_label>Healthy participants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individual with a gastrointestinal motility disorder that has failed both clinical and&#xD;
             surgical options for symptomatic management&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Child 17 years of age or younger&#xD;
&#xD;
          -  Individuals incapable of informed consent&#xD;
&#xD;
          -  Patient with diseased skin or on drugs which affect skin biology.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pankaj J Pasricha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pankaj J Pasricha, MD</last_name>
    <phone>4105506766</phone>
    <email>pasricha@jhu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillermo A Barahona, MD</last_name>
    <phone>4106038343</phone>
    <email>gbaraho1@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Bayview Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Small Fiber Neuropathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

